L

LiliumX

10 employees

LiliumX discovers new bispecific antibodies against cancer by utilizing a protein technology platform to facilitate the scalable discovery.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics
Health Care

Date founded

2021

Funding rounds raised

L

LiliumX raised undisclosed on May 28, 2021

Investors: Hoxton Ventures and Magnet Venture

L

LiliumX raised undisclosed on March 22, 2021

Investors: Y Combinator

FAQ